Trump Extends Iran Ceasefire but Market Focus Shifts to Broader Economic Signals Precision Optics Reports 108 Revenue Surge in Q3 Loss Narrows Significantly Cramer Nvidia Should Sell AI Chips in China to Maintain US Tech Edge Kevin Warsh Confirmed as Federal Reserve Chair in Historic Vote Should a 63YearOld With 14 Million Convert to a Roth While Expecting to Live to 100 General Motors Unveils AllElectric Cadillac Vistiq with 300Mile Range Beyond SpaceX Publicly Traded Space Stocks May Offer Opportunities Deadly Shanxi Coal Mine Blast Could Reshape Chinas Mining Safety and Coal Sector India Government Plans Tax Administration Overhaul for Smooth GST Rollout Report US Stock Futures Slide as Putins Nuclear Doctrine Shift Rattles Markets AL Q4 2025 Earnings EPS Surges Past Estimates by 239 TD SYNNEX SNX Q1 2026 Earnings Massive EPS Beat Drives Optimism Revenue Not Disclosed RRR Q1 2026 Earnings Earnings Beat Estimates as Stock Rises 332 ONON Q1 2026 Earnings EPS Smashes Estimates with 5146 Surprise Shares Edge Higher ZBIO Q1 2026 Earnings NarrowerThanExpected Loss Caps a Quarter of Pipeline Progress THM Q1 2026 Earnings Modest Profit Reported Amid No Revenue and Market Pullback Amylyx Pharmaceuticals AMLX Sees Uptick Amid Key Resistance Test Biotech Stock Gains 285 Urban Outfitters URBN Edges Lower as Traders Eye Key Support PSIX Edges Lower Amid Tight Trading Range Key Support and Resistance Levels in Focus Rush Enterprises RUSHA Retreats 154 Approaching Support Level Amid Broader Sector Weakness Avalo Therapeutics AVTX Holds Steady Near Key Support Levels Toast Inc TOST Rises 188 Navigating Support and Resistance in a Volatile Market Green Plains GPRE Jumps 210 on Strong Momentum 20260515 Inside The New York Times Bestseller Lists The Process and the Pushback from Authors Florida Homeowners Face Surging Insurance Costs Paying 3400 Above National Average Option OPCH Delivers Q1 2026 Beat EPS 040 vs 038 Expected Bitcoin Price Update May 14 2026 Latest Market Snapshot US Consumer Prices Accelerate 38 in April Marking Highest Annual Gain Since May 2023 MS Q1 2026 Earnings Strong EPS Beat Driven by Wealth Management and Trading Cadrenal Therapeutics CVKD Holds Steady Consolidating Between Support and Resistance